Literature DB >> 30250617

Unfolded protein response, a link between endometrioid ovarian carcinoma and endometriosis: A pilot study.

Andrea Ciavattini1, Giovanni Delli Carpini1, Matteo Serri1, Alessandra Tozzi1, Francesca Leoni2, Eugenia Di Loreto1, Franca Saccucci2.   

Abstract

The aim of the present study was to analyze the expression profile of unfolded protein response (UPR) genes in endometrioid ovarian carcinoma and to evaluate its possible involvement in the neoplastic progression of endometriosis. An experimental retrospective pilot study was conducted on women with a diagnosis of endometrioid ovarian carcinoma at FIGO stage IA, ovarian endometriotic cysts or healthy subjects without a previous diagnosis of endometriosis. The expression profiles of UPR genes (ATF6, GRP78, CHOP and XBP1) were compared among ovaries with endometrioid ovarian cancer, endometriotic ovarian cysts, healthy contralateral ovaries and eutopic and healthy endometrial tissues. A significantly higher expression of ATF6 and GRP78 was detected in the affected ovaries in comparison with the healthy contralateral ovaries, while CHOP and XBP1 exhibited a significantly lower expression. XBP1 was overexpressed in endometrial tissues and its expression gradually decreased in endometriosis cysts and endometrioid ovarian carcinoma. These results support the hypothesis that alterations in the UPR genes CHOP and XBP1 are involved in the neoplastic progression of endometrioid ovarian cancer and are acquired following ovarian localization of ectopic endometrial cells.

Entities:  

Keywords:  endometrioid ovarian cancer; endometrioma; endometriosis; unfolded protein response

Year:  2018        PMID: 30250617      PMCID: PMC6144292          DOI: 10.3892/ol.2018.9256

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.

Authors:  Richard O Burney; Said Talbi; Amy E Hamilton; Kim Chi Vo; Mette Nyegaard; Camran R Nezhat; Bruce A Lessey; Linda C Giudice
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

3.  Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.

Authors:  Ramachandra K Reddy; Changhui Mao; Peter Baumeister; Richard C Austin; Randal J Kaufman; Amy S Lee
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

4.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.

Authors:  Masahiro Shuda; Nobuo Kondoh; Nobuo Imazeki; Kenji Tanaka; Tetsuya Okada; Kazutoshi Mori; Akiyuki Hada; Masaaki Arai; Toru Wakatsuki; Osamu Matsubara; Naoki Yamamoto; Mikio Yamamoto
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

5.  The prevalence of endometriosis in women with infertile partners.

Authors:  K G Waller; P Lindsay; P Curtis; R W Shaw
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-02       Impact factor: 2.435

6.  Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress.

Authors:  Rajarshi Ghosh; Likun Wang; Eric S Wang; B Gayani K Perera; Aeid Igbaria; Shuhei Morita; Kris Prado; Maike Thamsen; Deborah Caswell; Hector Macias; Kurt F Weiberth; Micah J Gliedt; Marcel V Alavi; Sanjay B Hari; Arinjay K Mitra; Barun Bhhatarai; Stephan C Schürer; Erik L Snapp; Douglas B Gould; Michael S German; Bradley J Backes; Dustin J Maly; Scott A Oakes; Feroz R Papa
Journal:  Cell       Date:  2014-07-10       Impact factor: 41.582

7.  p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose.

Authors:  Anne-Laure Huber; Justine Lebeau; Patricia Guillaumot; Virginie Pétrilli; Mouhannad Malek; Julien Chilloux; Frédérique Fauvet; Léa Payen; Alain Kfoury; Toufic Renno; Eric Chevet; Serge N Manié
Journal:  Mol Cell       Date:  2013-02-07       Impact factor: 17.970

Review 8.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

Review 9.  FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.

Authors:  Jaime Prat
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

10.  ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells.

Authors:  Lukas Niederreiter; Teresa M J Fritz; Timon E Adolph; Anna-Maria Krismer; Felix A Offner; Markus Tschurtschenthaler; Magdalena B Flak; Shuhei Hosomi; Michal F Tomczak; Nicole C Kaneider; Edina Sarcevic; Sarah L Kempster; Tim Raine; Daniela Esser; Philip Rosenstiel; Kenji Kohno; Takao Iwawaki; Herbert Tilg; Richard S Blumberg; Arthur Kaser
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

View more
  3 in total

Review 1.  Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer.

Authors:  Tianming Zhao; Juan Du; Hui Zeng
Journal:  J Hematol Oncol       Date:  2020-12-02       Impact factor: 17.388

2.  Levels of endoplasmic reticulum stress-related mRNA in peritoneal fluid of patients with endometriosis or gynaecological cancer.

Authors:  Seung Geun Yeo; Sung Jong Lee; Ji Woo Lee; Sujung Oh; Dong Choon Park
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

Review 3.  Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis.

Authors:  Natalia Siwecka; Wioletta Rozpędek; Dariusz Pytel; Adam Wawrzynkiewicz; Adam Dziki; Łukasz Dziki; J Alan Diehl; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.